Second-line pharmacotherapy intensification after metformin monotherapy in type 2 diabetes: a nationwide register study from Finland during 2011-2022.
二型糖尿病中,單一使用 metformin 後的第二線藥物治療強化:2011-2022 年芬蘭的全國登記研究。
BMC Health Serv Res 2024-08-19
Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020-Nationwide Data from a Register-Based Analysis.
2015年至2020年間匈牙利2型糖尿病患者抗高血糖治療模式的變化-來自基於登記資料的全國性分析。
Medicina (Kaunas) 2023-03-08
Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study.
第二線組合治療對第二型糖尿病疾病控制的影響:一項基於人群的 cohort 研究。
Drugs Real World Outcomes 2023-09-22
Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom.
美國和英國第二線藥物治療在第2型糖尿病中的應用現代趨勢。
Diabetes Obes Metab 2024-02-10
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.
LEGEND-T2DM 中各心血管風險群體第二線抗高血糖藥物啟動的跨國模式:聯邦藥物流行病學評估。
BMJ Med 2024-03-30
Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010-2020: A retrospective population-based cohort study.
蘇格蘭2010年至2020年2型糖尿病患者初始及首次加劇使用抗糖尿病藥物的模式:一項回顧性人口基礎的世代研究。
Diabetes Obes Metab 2024-04-01
Treating Type 2 Diabetes With Early, Intensive, Multimodal Pharmacotherapy: Real-World Evidence From an International Collaborative Database.
以早期、密集、多模式藥物治療治療2型糖尿病:來自國際合作數據庫的實證。
J Diabetes Res 2024-06-07
Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022.
2018-2022 年澳洲 Metformin 之後首次加用抗高血糖療法的使用情況、時間及類型。
Br J Clin Pharmacol 2024-09-03